Search details
1.
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
Diabetes Obes Metab
; 26(4): 1395-1406, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38287130
Results
1 -
1
de 1
1
Next >
>>